Should a patient remain nil per os (NPO) after receiving Tenecteplase (TNK)?

NPO Status After TNK Administration

You do not need to remain strictly NPO after receiving TNK (tenecteplase), but you should minimize oral intake and avoid intramuscular injections for the first few hours post-administration due to bleeding risk.

Primary Considerations

The FDA label for TNK explicitly states to "avoid intramuscular injections and nonessential handling of the patient for the first few hours following treatment with TNKase" 1. This precaution is specifically about bleeding risk, not aspiration risk from oral intake.

Key Management Points

Bleeding Precautions (First Few Hours):

• Minimize patient handling and avoid unnecessary procedures
• Perform arterial and venous punctures carefully and only as required
• Avoid internal jugular and subclavian venous punctures (noncompressible sites)
• If arterial puncture is necessary, use upper extremity vessels accessible to manual compression and apply pressure for at least 30 minutes 1

Regarding Oral Intake: The guidelines and FDA labeling do not mandate NPO status after TNK administration. The concern is hemorrhagic complications, not aspiration risk. The 2025 ACC/AHA guidelines emphasize that patients should be transferred to a PCI-capable center immediately after fibrinolytic therapy for early angiography between 2-24 hours 2, 3, but do not specify NPO requirements.

Clinical Context

For STEMI patients receiving TNK:

• The focus is on monitoring for bleeding complications, reperfusion arrhythmias, and signs of failed reperfusion 2, 3
• Patients typically proceed to cardiac catheterization within 2-24 hours 2, 3
• Standard pre-catheterization NPO protocols would then apply (though recent evidence suggests routine NPO before cardiac catheterization may be unnecessary 4)

Practical Approach:

• Light oral intake is generally acceptable after TNK unless the patient is proceeding immediately to catheterization
• Apply standard NPO guidelines (typically 2 hours for clear liquids, 6-8 hours for solids) only if cardiac catheterization is imminent
• Prioritize bleeding precautions over strict NPO status in the immediate post-TNK period

Common Pitfalls to Avoid

1. Confusing bleeding precautions with aspiration precautions - The "avoid" language in the FDA label refers to procedures that could cause bleeding, not oral intake
2. Unnecessary prolonged fasting - Extended NPO periods can lead to dehydration, patient discomfort, and potentially worse outcomes 5
3. Missing the transfer window - Focus should be on rapid transfer to PCI-capable facility, not on maintaining NPO status 2, 3

The evidence clearly prioritizes bleeding risk management and timely transfer for angiography over routine NPO restrictions after TNK administration.